Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.35 |
| ▸ | ERN1 | O75460 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1949830 | 0.83 | — | — | |
| SCHEMBL1949903 | 0.76 | CYP2A6 (0.37) | CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1 | |
| SCHEMBL2105957 | 0.75 | ALDH1A1 (0.32) | CYP2A6ALDH1A1CYP1A2CYP3A4CYP11B1 | |
| SCHEMBL1949209 | 0.75 | S1PR1 (0.36) | S1PR1ADORA2A | |
| SCHEMBL1948168 | 0.74 | DGAT1 (0.38) | DGAT1 | |
| SCHEMBL1948211 | 0.74 | MEN1 (0.33) | NPC1MEN1 | |
| SCHEMBL1949088 | 0.74 | ENPP1 (0.38) | PDK2ADORA2BADORA2A | |
| SCHEMBL1946938 | 0.74 | ERN1 (0.36) | CYP2A6ALDH1A1CYP1A2CYP3A4ERN1 | |
| SCHEMBL1950883 | 0.73 | TRPA1 (0.30) | — | |
| SCHEMBL1949127 | 0.72 | PIK3CD (0.31) | CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9084420-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-04-17 | — | — | US | disclosed |
| US-8633228-B2 | Amide derivative, pest control agent containing the amide derivative, and pest controlling method | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | Mitsui Chemicals Agro., Inc. (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136878-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | CYP2A6 840/4885ALDH1A1 1837/4885CYP1A2 454/4885 |
| US-20140107368-A1 | AMIDE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE AMIDE DERIVATIVE, AND PEST CONTROLLING METHOD | L3MBTL1, L3MBTL4, L3MBTL3 | CYP2A6 840/4885ALDH1A1 1837/4885CYP1A2 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.